About deferasiroxa synthetic achiral, tridentate triazole derived from salicylic acid, oral iron chelating agents.indication for the treatment of chronic iron overload due to blood transfusions (transfusional hemosiderosis) in patients 2 years of age and older.mechanism of actiontwo molecules of deferasirox are capable of binding to 1 atom of iron. deferasirox works in treating iron toxicity by binding trivalent (ferric) iron (for which it has a strong affinity), forming a stable complex which is eliminated via the kidneys.